Form 4: Willis Towers Watson Executive Acquires Restricted Share Units

Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson, reports acquisition of restricted share units.

Summary

• On July 10, 2024, Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson PLC, acquired 64.0554 restricted share units at a price of $258.16.
• These restricted share units will settle for ordinary shares on a 1:1 basis six months after the reporting person's termination date.
• Gebauer also holds 22,976.1728 ordinary shares directly.
• The transactions include restricted share units acquired through the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects routine executive compensation and investment in the company's stock.

Positives

• The acquisition of restricted share units indicates continued investment in the company by a key executive.

Future Outlook

The restricted share units will convert to ordinary shares six months after the reporting person's termination date.

Industry Context

Executive compensation often includes restricted share units to align management's interests with those of shareholders. This filing is a routine disclosure related to such compensation.

Comparison to Industry Standards

• Companies like Aon and Mercer also use restricted share units as part of their executive compensation packages.
• The vesting schedules and terms of these units are generally comparable across the industry, often tied to tenure or performance metrics.

Stakeholder Impact

• The transaction signals continued commitment from a key executive, which can positively influence shareholder confidence.

Key Dates